The antibody drug conjugate VLS-101 targeting ROR1 is effective in CAR T-resistant mantle cell lymphoma

Overview of attention for article published in Journal of Hematology & Oncology, August 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 32 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 9 X posts from 7 X users, with an upper bound of 21,181 followers.

RT @michaelwangmd: In a study from the Wang Lab, aberrant ROR1 expression in CAR-T relapsed MCL tumors was targeted using VLS-101, an anti-…

02 Sep 2021

Reply Repost Favourite

RT @michaelwangmd: In a study from the Wang Lab, aberrant ROR1 expression in CAR-T relapsed MCL tumors was targeted using VLS-101, an anti-…

01 Sep 2021

Reply Repost Favourite

In a study from the Wang Lab, aberrant ROR1 expression in CAR-T relapsed MCL tumors was targeted using VLS-101, an anti-ROR1 antibody that showed potent anti-MCL activity in vitro & regression in PDX models. https://t.co/d0uNZ3rFV9

01 Sep 2021

Reply Repost Favourite

The antibody drug conjugate VLS-101 targeting ROR1 is effective in CAR T-resistant mantle cell #lymphoma. #MCL https://t.co/qdCluOAHHX

30 Aug 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.